Balyasny Asset Management LLC Bluebird Bio, Inc. Transaction History

Balyasny Asset Management LLC

$58 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$0.85 - $1.26 $192,954 - $286,026	227,005 New	227,005 $222,000
Q4 2023 Feb 14, 2024	BUY	$1.32 - $4.83 $45,066 - $164,901	34,141 New	34,141 $47,000
Q1 2023 May 15, 2023	BUY	$3.14 - $8.22 $1.58 Million - $4.13 Million	502,632 Added 53.04%	1,450,239 $4.61 Million
Q4 2022 Feb 14, 2023	BUY	$5.77 - $8.49 $4.78 Million - $7.04 Million	829,274 Added 700.8%	947,607 $6.56 Million
Q3 2022 Nov 14, 2022	BUY	$3.75 - $7.39 $102,393 - $201,783	27,305 Added 30.0%	118,333 $749,000
Q2 2022 Aug 15, 2022	BUY	$2.94 - $5.23 $267,622 - $476,076	91,028 New	91,028 $377,000
Q1 2021 May 17, 2021	SELL	$16.59 - $33.89 $479,451 - $979,421	-28,900 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$27.5 - $37.92 $1.74 Million - $2.39 Million	-63,114 Reduced 68.59%	28,900 $809,000
Q3 2020 Nov 16, 2020	BUY	$34.44 - $43.75 $3.17 Million - $4.03 Million	92,014 New	92,014 $4.96 Million
Q3 2019 Nov 14, 2019	SELL	$59.47 - $93.1 $1.06 Million - $1.67 Million	-17,903 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$75.84 - $105.21 $3.55 Million - $4.93 Million	-46,835 Reduced 72.35%	17,903 $2.28 Million
Q1 2019 May 15, 2019	SELL	$64.44 - $104.11 $421,630 - $681,191	-6,543 Reduced 9.18%	64,738 $10.2 Million
Q4 2018 Feb 14, 2019	SELL	$59.1 - $93.26 $9.72 Million - $15.3 Million	-164,506 Reduced 69.77%	71,281 $7.07 Million
Q3 2018 Nov 14, 2018	SELL	$88.86 - $117.49 $2.33 Million - $3.08 Million	-26,203 Reduced 10.0%	235,787 $34.4 Million
Q2 2018 Aug 14, 2018	BUY	$99.64 - $127.59 $4.68 Million - $5.99 Million	46,951 Added 21.83%	261,990 $41.1 Million
Q1 2018 May 15, 2018	BUY	$105.8 - $150.94 $1.53 Million - $2.19 Million	14,506 Added 7.23%	215,039 $36.7 Million
Q4 2017 Feb 14, 2018	SELL	$81.25 - $130.7 $24.6 Million - $39.5 Million	-302,589 Reduced 60.14%	200,533 $35.7 Million
Q3 2017 Nov 14, 2017	BUY	$57.74 - $91.42 $29.1 Million - $46 Million	503,122	503,122 $69.1 Million

Others Institutions Holding BLUE

# of Institutions

152

Shares Held

63.7M

Call Options Held

264K

Put Options Held

428K

Black Rock Inc. New York, NY

15.4M
Shares

$4.94 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

10.5M
Shares

$3.35 Million
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

4.68M
Shares

$1.5 Million
0.0% of portfolio
Pictet Asset Management Sa Geneva 73, V8

4.67M
Shares

$1.49 Million
0.02% of portfolio
State Street Corp Boston, MA

3.84M
Shares

$1.23 Million
0.0% of portfolio

View Full List

About bluebird bio, Inc.

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $24.7M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

More about BLUE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Account